0
20. 5. 2016.
The effects of delayed imatinib mesylate treatment on outcome in patients with GIST.
e22518Background: Cancer patients in developing and low income countries have limited access to target therapies. Many patients with gastrointestinal stromal tumors (GIST) have had to wait for exte...